Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert


Search Title by author or title

Descemet's membrane endothelial keratoplasty (DMEK) in the presence of iris prosthesis

Poster Details

First Author: N. Gerber-Hollbach SWITZERLAND

Co Author(s):    D. Goldblum                    

Abstract Details


Descemet membrane endothelial keratoplasty (DMEK) is gaining popularity not only as a primary treatment for endothelial dysfunction but also as secondary treatment option after complicated primary DMEK surgery, in the presence of glaucoma devices or anterior chamber lenses. We first present a new DMEK surgery technique in the presence of an artificial iris diaphragm.


University Eye Hospital Basel, Primary Care Center


DMEK surgery was performed in a 89-year-old patient that presented after complicated cataract surgery with a subtotal iatrogenic iridodialysis. Ten months after implantation of an artificial iris he developed a bullous pseudophakic keratopathy. Endothelial keratoplasty was performed using a new modified “No-touch” surgery technique with continuous air flow and a 7.75mm graft.


BCVA improved to 0.9 at three months after keratoplasty. Endothelial cell density counting showed a 29% decrease, central corneal thickness a 19% decrease at three months after surgery compared to preoperative values.


Due to the shallow anterior chamber and the stiff iris/lens diaphragm manipulation of the graft, fluid/air exchanges and pressurization of the eye were challenging. With some modifications and the use of an anterior chamber maintainer DMEK is a feasible and successful treatment option in the presence of an iris prothesis. Clinical outcomes at 3 months seem comparable with standard DMEK surgery.

Financial Disclosure:


Back to Poster listing